Zymeworks Inc.
NASDAQZYME enters the final days of August with an unusual combination: short sellers adding to positions at the fastest weekly pace in months, while options traders have swung to one of the most bullish readings of the past year. The options signal is the most striking data point this week. Call demand has overwhelmed puts, driving the put/call ratio down to 0.13 — nearly three standard…
Snapshot as of 20 Sept 2026
ZYME enters the final days of August with an unusual combination: short sellers adding to positions at the fastest weekly pace in months, while options traders have swung to one of the most bullish readings of the past…
ZYME reports Q2 results tomorrow evening with a split signal: options traders are more cautious than usual, while the analyst community just raised its target for the stock ahead of the print. The clearest near-term…
Zymeworks enters June with a growing gap between where analysts think it should trade and where it actually is — a widening that has become the defining tension of the past month. The stock closed at $24.11 on June 2,…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ZYME — free to start on ORTEX.
Sign up for free →Open ZYME on ORTEX